{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:33:15Z","timestamp":1776209595306,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/ki.2009.200","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T12:41:22Z","timestamp":1244637682000},"page":"567-575","source":"Crossref","is-referenced-by-count":63,"title":["Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients"],"prefix":"10.1016","volume":"76","author":[{"given":"Christiane","family":"Drechsler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the German Diabetes and Dialysis Study Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Krane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedo W.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.200_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2009.200_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1470173","article-title":"Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women","volume":"147","author":"Matsubara","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/ki.2009.200_bb0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.200_bb0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.200_bb0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.200_bb0035","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/ndt\/gfn376","article-title":"The emerging biology of adipose tissue in chronic kidney disease: from fat to facts","volume":"23","author":"Axelsson","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.200_bb0040","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"key":"10.1038\/ki.2009.200_bb0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.200_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumada","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.200_bb0055","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1038\/ki.2009.200_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","article-title":"Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.200_bb0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.2004090742","article-title":"Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study","volume":"16","author":"Becker","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.200_bb0070","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1681\/ASN.2006040331","article-title":"Adiponectin and mortality in patients with chronic kidney disease","volume":"17","author":"Menon","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.200_bb0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.ki.5002191","article-title":"Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study","volume":"71","author":"Kollerits","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.200_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.200_bb0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.ajkd.2004.02.017","article-title":"Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function","volume":"43","author":"Huang","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.200_bb0090","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.amjcard.2006.07.039","article-title":"Adiponectin and renal function, and implication as a risk of cardiovascular disease","volume":"98","author":"Iwashima","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2009.200_bb0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2008.201","article-title":"Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy","volume":"74","author":"Jorsal","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.200_bb0100","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2007.11.001","article-title":"Excerpts from the United States Renal Data System 2007 annual data report","volume":"51","author":"Collins","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.200_bb0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehm033","article-title":"Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide","volume":"28","author":"McEntegart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.200_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2006091050","article-title":"Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up","volume":"18","author":"de Mutsert","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.200_bb0115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.200_bb0120","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.200_bb0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.200_bb0130","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.200_bb0135","doi-asserted-by":"crossref","first-page":"c103","DOI":"10.1159\/000108651","article-title":"Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus","volume":"107","author":"Komaba","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2009.200_bb0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1291\/hypres.31.825","article-title":"Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects","volume":"31","author":"Ohara","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1038\/ki.2009.200_bb0145","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/eurheartj\/ehn009","article-title":"Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study","volume":"29","author":"Schnabel","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.200_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijcard.2007.12.002","article-title":"Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study","volume":"125","author":"Haugen","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1038\/ki.2009.200_bb0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejheart.2008.02.005","article-title":"Effect of atrial natriuretic peptide on adiponectin in patients with heart failure","volume":"10","author":"Tanaka","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/ki.2009.200_bb0160","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/eurheartj\/ehn278","article-title":"Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients","volume":"29","author":"Winkler","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.200_bb0165","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/ndt\/gfn070","article-title":"Plasma adiponectin levels and clinical outcomes among haemodialysis patients","volume":"23","author":"Rao","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.200_bb0170","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/eurheartj\/ehl153","article-title":"Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain","volume":"27","author":"Cavusoglu","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.200_bb0175","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1210\/jc.2006-0836","article-title":"Adiponectin and mortality in patients undergoing coronary angiography","volume":"91","author":"Pilz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.200_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-139X.2008.00455.x","article-title":"Sudden cardiac death and dialysis patients","volume":"21","author":"Herzog","year":"2008","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2009.200_bb0185","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.04571007","article-title":"The challenge of sudden death in dialysis patients","volume":"3","author":"Ritz","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.200_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","article-title":"Adiponectin as an anti-inflammatory factor","volume":"380","author":"Ouchi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1038\/ki.2009.200_bb0195","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbrc.2004.09.177","article-title":"AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells","volume":"324","author":"Cacicedo","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2009.200_bb0200","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.108.163303","article-title":"Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop","volume":"28","author":"Devaraj","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.200_bb0205","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.RES.0000194328.57164.36","article-title":"Adiponectin inhibits endothelial synthesis of interleukin-8","volume":"97","author":"Kobashi","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/ki.2009.200_bb0210","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1074\/jbc.M310389200","article-title":"Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells","volume":"279","author":"Ouchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2009.200_bb0215","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","article-title":"Adiponectin protects against myocardial ischemia\u2013reperfusion injury through","volume":"11","author":"Shibata","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.200_bb0220","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.200_bb0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI29709","article-title":"Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies","volume":"117","author":"Takemura","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.200_bb0230","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nri957","article-title":"A blast from the past: clearance of apoptotic cells regulates immune responses","volume":"2","author":"Savill","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/ki.2009.200_bb0235","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2008.484","article-title":"Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis","volume":"74","author":"Krane","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.200_bb0240","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.200_bb0245","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2265.2007.03063.x","article-title":"Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy","volume":"68","author":"Kato","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1038\/ki.2009.200_bb0250","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.phrs.2007.09.014","article-title":"Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk","volume":"56","author":"Giannessi","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1038\/ki.2009.200_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jri.2006.05.004","article-title":"Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia","volume":"73","author":"Takemura","year":"2007","journal-title":"J Reprod Immunol"},{"key":"10.1038\/ki.2009.200_bb0260","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehm154","article-title":"Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure","volume":"28","author":"Tsutamoto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2009.200_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000080241","article-title":"Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics","volume":"27","author":"Wanner","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"10.1038\/ki.2009.200_bb0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ki.5002650","article-title":"Confounding: what it is and how to deal with it","volume":"73","author":"Jager","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.200_bb0275","series-title":"Modern Epidemiology","first-page":"192","article-title":"Confounding and selection bias","author":"Rothman","year":"2008"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T06:29:23Z","timestamp":1633588163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815540027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0085253815540027"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.200","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}